Reco: REDUCE
CMP: Rs 357
Target Price: Rs 350
- Q1FY13 results were better than est driven by better chemicals performance & higher other income. Revenues stood at Rs 14.1bn, 17% yoy while PAT at Rs 1.7bn, -3% yoy.
- Chemicals revenues were supported by higher volumes of caprolactam/ nylon & intermediates trading as company achieved record level production in the quarter.
- Though chemicals outperformed in Q1; however outlook remains weak. Capro-benzene spreads have declined further by 18% to $1100/mt (Q1FY13 avg spreads stood at $1350/mt).
- We maintain our reduce rating since margin pressure in chemical segment continues and await for reversal in chemical spread.